{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:35:48Z","timestamp":1794645348397,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG057468"],"award-info":[{"award-number":["T32AG057468"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Patrick Grange Memorial Foundation"},{"name":"Mitsubishi Tanabe Pharma America"},{"name":"Hiller Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52496-6","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:46:05Z","timestamp":1778859965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Axonal dying back of upper motor neurons in human ALS"],"prefix":"10.1038","volume":"16","author":[{"given":"Haley C.","family":"Cropper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fozia","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Dachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidushi R.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ramizuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Kopecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebony","family":"Mocanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Valyi-Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mnatsakanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles K.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"6229","key":"52496_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli, E. T. et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347 (6229), 1436\u20131441 (2015).","journal-title":"Science"},{"issue":"3","key":"52496_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","volume":"12","author":"MR Turner","year":"2013","unstructured":"Turner, M. R. et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 12 (3), 310\u2013322 (2013).","journal-title":"Lancet Neurol."},{"key":"52496_CR3","doi-asserted-by":"crossref","unstructured":"Grad, L. I. et al. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Cold Spring Harb Perspect. Med., 7(8). (2017).","DOI":"10.1101\/cshperspect.a024117"},{"issue":"10","key":"52496_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","volume":"73","author":"JM Ravits","year":"2009","unstructured":"Ravits, J. M., La, A. R. & Spada ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73 (10), 805\u2013811 (2009).","journal-title":"Neurology"},{"issue":"19","key":"52496_CR5","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1212\/01.wnl.0000260965.20021.47","volume":"68","author":"J Ravits","year":"2007","unstructured":"Ravits, J., Paul, P. & Jorg, C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 68 (19), 1571\u20131575 (2007).","journal-title":"Neurology"},{"issue":"3","key":"52496_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/156720511795563700","volume":"8","author":"R Ferrari","year":"2011","unstructured":"Ferrari, R. et al. FTD and ALS: a tale of two diseases. Curr. Alzheimer Res. 8 (3), 273\u2013294 (2011).","journal-title":"Curr. Alzheimer Res."},{"key":"52496_CR7","doi-asserted-by":"crossref","unstructured":"Menon, P. & Vucic, S. The Upper Motor Neuron-Improved Knowledge from ALS and Related Clinical Disorders. Brain Sci., 11(8). (2021).","DOI":"10.3390\/brainsci11080958"},{"issue":"4","key":"52496_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jon199774208","volume":"7","author":"K Abe","year":"1997","unstructured":"Abe, K. et al. Degeneration of the pyramidal tracts in patients with amyotrophic lateral sclerosis. A premortem and postmortem magnetic resonance imaging study. J. Neuroimaging. 7 (4), 208\u2013212 (1997).","journal-title":"J. Neuroimaging"},{"issue":"2","key":"52496_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/hbm.23412","volume":"38","author":"A Sarica","year":"2017","unstructured":"Sarica, A. et al. The corticospinal tract profile in amyotrophic lateral sclerosis. Hum. Brain Mapp. 38 (2), 727\u2013739 (2017).","journal-title":"Hum. Brain Mapp."},{"key":"52496_CR10","doi-asserted-by":"publisher","first-page":"947347","DOI":"10.3389\/fneur.2022.947347","volume":"13","author":"C Zejlon","year":"2022","unstructured":"Zejlon, C. et al. Structural magnetic resonance imaging findings and histopathological correlations in motor neuron diseases-A systematic review and meta-analysis. Front. Neurol. 13, 947347 (2022).","journal-title":"Front. Neurol."},{"key":"52496_CR11","doi-asserted-by":"publisher","first-page":"122945","DOI":"10.1016\/j.jns.2024.122945","volume":"459","author":"V Rajagopalan","year":"2024","unstructured":"Rajagopalan, V. & Pioro, E. P. Differing patterns of cortical grey matter pathology identified by multifractal analysis in UMN-predominant ALS patients with and without corticospinal tract hyperintensity. J. Neurol. Sci. 459, 122945 (2024).","journal-title":"J. Neurol. Sci."},{"key":"52496_CR12","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.nicl.2017.02.017","volume":"14","author":"V Rajagopalan","year":"2017","unstructured":"Rajagopalan, V. & Pioro, E. P. Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: A diffusion tensor tractography study. Neuroimage Clin. 14, 574\u2013579 (2017).","journal-title":"Neuroimage Clin."},{"issue":"8","key":"52496_CR13","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/jnnp.2010.236018","volume":"82","author":"CR Blain","year":"2011","unstructured":"Blain, C. R. et al. Differential corticospinal tract degeneration in homozygous \u2018D90A\u2019 SOD-1 ALS and sporadic ALS. J. Neurol. Neurosurg. Psychiatry. 82 (8), 843\u2013849 (2011).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"52496_CR14","doi-asserted-by":"crossref","unstructured":"Rajagopalan, V. & Pioro, E. P. Corticospinal Tract and Related Grey Matter Morphometric Shape Analysis in ALS Phenotypes: A Fractal Dimension Study. Brain Sci., 11(3). (2021).","DOI":"10.3390\/brainsci11030371"},{"key":"52496_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fneur.2018.00364","volume":"9","author":"D Shen","year":"2018","unstructured":"Shen, D. et al. Brain Structural and Perfusion Signature of Amyotrophic Lateral Sclerosis With Varying Levels of Cognitive Deficit. Front. Neurol. 9, 364 (2018).","journal-title":"Front. Neurol."},{"issue":"Pt 2","key":"52496_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/brain\/115.2.495","volume":"115","author":"CE Pringle","year":"1992","unstructured":"Pringle, C. E. et al. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 115 (Pt 2), 495\u2013520 (1992).","journal-title":"Brain"},{"issue":"22","key":"52496_CR17","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1212\/WNL.0b013e3181a8269b","volume":"72","author":"PH Gordon","year":"2009","unstructured":"Gordon, P. H. et al. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology 72 (22), 1948\u20131952 (2009).","journal-title":"Neurology"},{"issue":"Pt 9","key":"52496_CR18","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1093\/brain\/awr178","volume":"134","author":"NK Iwata","year":"2011","unstructured":"Iwata, N. K. et al. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 134 (Pt 9), 2642\u20132655 (2011).","journal-title":"Brain"},{"issue":"3","key":"52496_CR19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351 (3), 602\u2013611 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5796","key":"52496_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (5796), 130\u2013133 (2006).","journal-title":"Science"},{"issue":"2","key":"52496_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann, M. et al. Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117 (2), 137\u2013149 (2009).","journal-title":"Acta Neuropathol."},{"issue":"1","key":"52496_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00401-016-1633-2","volume":"133","author":"H Braak","year":"2017","unstructured":"Braak, H. et al. Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal alpha-motoneurons in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 133 (1), 79\u201390 (2017).","journal-title":"Acta Neuropathol."},{"key":"52496_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fnins.2014.00252","volume":"8","author":"EB Moloney","year":"2014","unstructured":"Moloney, E. B., de Winter, F. & Verhaagen, J. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 8, 252 (2014).","journal-title":"Front. Neurosci."},{"issue":"2","key":"52496_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","volume":"185","author":"LR Fischer","year":"2004","unstructured":"Fischer, L. R. et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185 (2), 232\u2013240 (2004).","journal-title":"Exp. Neurol."},{"issue":"8","key":"52496_CR25","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/00001756-199605310-00021","volume":"7","author":"PF Kennel","year":"1996","unstructured":"Kennel, P. F. et al. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. Neuroreport 7 (8), 1427\u20131431 (1996).","journal-title":"Neuroreport"},{"issue":"1","key":"52496_CR26","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1038\/s41598-021-85801-6","volume":"11","author":"F Dachet","year":"2021","unstructured":"Dachet, F. et al. Selective time-dependent changes in activity and cell-specific gene expression in human postmortem brain. Sci. Rep. 11 (1), 6078 (2021).","journal-title":"Sci. Rep."},{"key":"52496_CR27","doi-asserted-by":"crossref","unstructured":"Young, K. & Morrison, H. Quantifying Microglia Morphology from Photomicrographs of Immunohistochemistry Prepared Tissue Using ImageJ. J. Vis. Exp., 2018(136).","DOI":"10.3791\/57648"},{"issue":"1","key":"52496_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4 (1), 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"issue":"W1","key":"52496_CR29","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50 (W1), W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"52496_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/archneurpsyc.1941.02280240094006","volume":"46","author":"C DAVISON","year":"1941","unstructured":"DAVISON, C. AMYOTROPHIC LATERAL SCLEROSIS: ORIGIN AND EXTENT OF THE UPPER MOTOR NEURON LESION. Archives Neurol. Psychiatry. 46 (6), 1039\u20131056 (1941).","journal-title":"Archives Neurol. Psychiatry"},{"issue":"5","key":"52496_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000433581","volume":"15","author":"G Coan","year":"2015","unstructured":"Coan, G. & Mitchell, C. S. An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies. Neurodegener Dis. 15 (5), 301\u2013312 (2015).","journal-title":"Neurodegener Dis."},{"key":"52496_CR32","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3389\/fnins.2019.00704","volume":"13","author":"V Rajagopalan","year":"2019","unstructured":"Rajagopalan, V. & Pioro, E. P. Unbiased MRI Analyses Identify Micropathologic Differences Between Upper Motor Neuron-Predominant ALS Phenotypes. Front. Neurosci. 13, 704 (2019).","journal-title":"Front. Neurosci."},{"issue":"12","key":"52496_CR33","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s002340050518","volume":"39","author":"M Waragai","year":"1997","unstructured":"Waragai, M. MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology 39 (12), 847\u2013851 (1997).","journal-title":"Neuroradiology"},{"issue":"1","key":"52496_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","volume":"74","author":"J Brettschneider","year":"2013","unstructured":"Brettschneider, J. et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 74 (1), 20\u201338 (2013).","journal-title":"Ann. Neurol."},{"key":"52496_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","volume":"3","author":"A Uchino","year":"2015","unstructured":"Uchino, A. et al. Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol. Commun. 3, 35 (2015).","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"52496_CR36","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1212\/WNL.61.6.750","volume":"61","author":"RW Haley","year":"2003","unstructured":"Haley, R. W. Excess incidence of ALS in young Gulf War veterans. Neurology 61 (6), 750\u2013756 (2003).","journal-title":"Neurology"},{"issue":"6","key":"52496_CR37","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.neuro.2008.05.005","volume":"29","author":"ML Miranda","year":"2008","unstructured":"Miranda, M. L. et al. Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans. Neurotoxicology 29 (6), 964\u2013970 (2008).","journal-title":"Neurotoxicology"},{"issue":"R2","key":"52496_CR38","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1093\/hmg\/ddx247","volume":"26","author":"T Niccoli","year":"2017","unstructured":"Niccoli, T., Partridge, L. & Isaacs, A. M. Ageing as a risk factor for ALS\/FTD. Hum. Mol. Genet. 26 (R2), R105\u2013R113 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"52496_CR39","doi-asserted-by":"crossref","unstructured":"Raymond, J. et al. Head Injury and Amyotrophic Lateral Sclerosis: Population-Based Study from the National ALS Registry. Brain Sci., 15(2). (2025).","DOI":"10.3390\/brainsci15020143"},{"issue":"6","key":"52496_CR40","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10072-011-0918-4","volume":"33","author":"A Al-Ajmi","year":"2012","unstructured":"Al-Ajmi, A., Rousseff, R. T. & Khuraibet, A. J. Clinically definite ALS presenting weeks after mild electric injury: causality or coincidence? Neurol. Sci. 33 (6), 1451\u20131453 (2012).","journal-title":"Neurol. Sci."},{"issue":"8","key":"52496_CR41","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/milmed\/166.8.731","volume":"166","author":"JE Riggs","year":"2001","unstructured":"Riggs, J. E. The latency between traumatic axonal injury and the onset of amyotrophic lateral sclerosis in young adult men. Mil Med. 166 (8), 731\u2013732 (2001).","journal-title":"Mil Med."},{"issue":"1","key":"52496_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/milmed\/158.1.55","volume":"158","author":"JE Riggs","year":"1993","unstructured":"Riggs, J. E. Antecedent trauma and amyotrophic lateral sclerosis in young adult men. Mil Med. 158 (1), 55\u201357 (1993).","journal-title":"Mil Med."},{"key":"52496_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.nbd.2018.12.020","volume":"124","author":"S Schram","year":"2019","unstructured":"Schram, S. et al. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury. Neurobiol. Dis. 124, 469\u2013478 (2019).","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"52496_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12974-020-01849-7","volume":"17","author":"S Schram","year":"2020","unstructured":"Schram, S., Loeb, J. A. & Song, F. Disease propagation in amyotrophic lateral sclerosis (ALS): an interplay between genetics and environment. J. Neuroinflammation. 17 (1), 175 (2020).","journal-title":"J. Neuroinflammation"},{"key":"52496_CR45","doi-asserted-by":"crossref","unstructured":"Liu, J. et al. Prevention of Alzheimer Pathology by Blocking Neuregulin Signaling on Microglia. eNeuro, 10(11). (2023).","DOI":"10.1523\/ENEURO.0422-23.2023"},{"key":"52496_CR46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.nbd.2017.12.012","volume":"111","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation. Neurobiol. Dis. 111, 118\u2013126 (2018).","journal-title":"Neurobiol. Dis."},{"issue":"6048","key":"52496_CR47","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli, R. C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333 (6048), 1456\u20131458 (2011).","journal-title":"Science"},{"issue":"9","key":"52496_CR48","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter, M. W. & Stevens, B. Microglia emerge as central players in brain disease. Nat. Med. 23 (9), 1018\u20131027 (2017).","journal-title":"Nat. Med."},{"issue":"8","key":"52496_CR49","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","volume":"19","author":"GW Kreutzberg","year":"1996","unstructured":"Kreutzberg, G. W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (8), 312\u2013318 (1996).","journal-title":"Trends Neurosci."},{"issue":"3","key":"52496_CR50","first-page":"289","volume":"80","author":"M Katsuno","year":"2018","unstructured":"Katsuno, M. et al. Preclinical progression of neurodegenerative diseases. Nagoya J. Med. Sci. 80 (3), 289\u2013298 (2018).","journal-title":"Nagoya J. Med. Sci."},{"key":"52496_CR51","doi-asserted-by":"crossref","unstructured":"Fullam, T. & Statland, J. Upper Motor Neuron Disorders: Primary Lateral Sclerosis, Upper Motor Neuron Dominant Amyotrophic Lateral Sclerosis, and Hereditary Spastic Paraplegia. Brain Sci., 11(5). (2021).","DOI":"10.3390\/brainsci11050611"},{"issue":"3\u20134","key":"52496_CR52","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0361-9230(93)90265-D","volume":"30","author":"AJ Hudson","year":"1993","unstructured":"Hudson, A. J. et al. Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis. Brain Res. Bull. 30 (3\u20134), 359\u2013364 (1993).","journal-title":"Brain Res. Bull."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52496-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52496-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52496-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:01:30Z","timestamp":1784077290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52496-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52496"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52496-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.A. is a consultant for Guidepoint Global, Atheneum Partners, Clarivate and the NIH. The authors report no other potential conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22167"}}